The critical step of navigating post-approval phase
Pharma unphased
Related Posts
Wearable technology to be offered to thousands with type 1 diabetes in UK
The condition affects around 270,935 people in England and 16,090 people in Wales The National Institute for Health and Care Excellence (NICE) […]
Food for thought – PharmaTimes
Weight loss drugs are the word on the street and it’s getting serious With all the noise surrounding ‘miracle’ weight loss drugs recently, it is […]
KCL and McMaster University partner to advance nuclear medicine research
Both partners’ will leverage their nuclear research facilities and expertise to develop new health interventions King’s College London’s (KCL) Biomedical Engineering and Imaging Sciences (BMEIS) […]